Literature DB >> 20018546

A hypothetical explanatory model for meningococcal meningitis in the African meningitis belt.

Judith E Mueller1, Bradford D Gessner.   

Abstract

Despite much progress in surveillance and biological research, no explanation exists to date for the epidemic pattern of meningitis in the African meningitis belt, which is required to mathematically model the impact of vaccine strategies or to predict epidemics. This paper presents a hypothetical explanatory model for epidemic meningococcal meningitis. Four incidence patterns are defined as model states, including endemic incidence during the rainy season, ubiquitous hyperendemicity during the dry season, occasional localized epidemics, and-at the regional level-regular epidemic waves spanning over communities or years. While the transition from endemic to hyperendemic situation in a community is caused by an increase in risk of meningitis given colonization by a virulent meningococcus (due to damage of the pharyngeal mucosa by dry climate), the transition from hyperendemic to epidemic situation involves increased pharyngeal colonization and transmission (possibly caused by viral respiratory infection epidemics). The described mechanisms are sufficient to explain the 10- to 100-fold incidence increase that both transitions usually imply. Epidemic waves occur if new meningococcal strains which escape pre-existing immunity, enter the population. Future research should include the impact of viral co-infection on bacterial colonization and invasion. Copyright 2009 International Society for Infectious Diseases. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20018546     DOI: 10.1016/j.ijid.2009.08.013

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  44 in total

1.  Linkages between observed, modeled Saharan dust loading and meningitis in Senegal during 2012 and 2013.

Authors:  Aminata Mbow Diokhane; Gregory S Jenkins; Noel Manga; Mamadou S Drame; Boubacar Mbodji
Journal:  Int J Biometeorol       Date:  2015-08-22       Impact factor: 3.787

2.  Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccine.

Authors:  Paul A Kristiansen; Fabien Diomandé; Stanley C Wei; Rasmata Ouédraogo; Lassana Sangaré; Idrissa Sanou; Denis Kandolo; Pascal Kaboré; Thomas A Clark; Abdoul-Salam Ouédraogo; Ki Ba Absatou; Charles D Ouédraogo; Musa Hassan-King; Jennifer Dolan Thomas; Cynthia Hatcher; Mamoudou Djingarey; Nancy Messonnier; Marie-Pierre Préziosi; Marc LaForce; Dominique A Caugant
Journal:  Clin Vaccine Immunol       Date:  2011-01-12

3.  Time is (still) of the essence: quantifying the impact of emergency meningitis vaccination response in Katsina State, Nigeria.

Authors:  Matthew J Ferrari; Florence Fermon; Fabienne Nackers; Augusto Llosa; Claire Magone; Rebecca F Grais
Journal:  Int Health       Date:  2014-09-05       Impact factor: 2.473

4.  A periodic disease transmission model with asymptomatic carriage and latency periods.

Authors:  Isam Al-Darabsah; Yuan Yuan
Journal:  J Math Biol       Date:  2017-12-22       Impact factor: 2.259

5.  Study of a localized meningococcal meningitis epidemic in Burkina Faso: incidence, carriage, and immunity.

Authors:  Judith E Mueller; Seydou Yaro; Berthe-Marie Njanpop-Lafourcade; Aly Drabo; Régina S Idohou; Sita S Kroman; Oumarou Sanou; Serge Diagbouga; Yves Traoré; Lassana Sangaré; Raymond Borrow; Bradford D Gessner
Journal:  J Infect Dis       Date:  2011-10-12       Impact factor: 5.226

6.  Streptococcus pneumoniae serotype 1 burden in the African meningitis belt: exploration of functionality in specific antibodies.

Authors:  S Blumental; J C Moïsi; L Roalfe; M Zancolli; M Johnson; P Burbidge; R Borrow; S Yaro; J E Mueller; B D Gessner; D Goldblatt
Journal:  Clin Vaccine Immunol       Date:  2015-02-04

7.  Cost-Effectiveness of Alternative Uses of Polyvalent Meningococcal Vaccines in Niger: An Agent-Based Transmission Modeling Study.

Authors:  S M Niaz Arifin; Christoph Zimmer; Caroline Trotter; Anaïs Colombini; Fati Sidikou; F Marc LaForce; Ted Cohen; Reza Yaesoubi
Journal:  Med Decis Making       Date:  2019-07-03       Impact factor: 2.583

8.  Evaluating the Impact of Meningococcal Vaccines With Synthetic Controls.

Authors:  Ottavia Prunas; Daniel M Weinberger; Duccio Medini; Michele Tizzoni; Lorenzo Argante
Journal:  Am J Epidemiol       Date:  2022-03-24       Impact factor: 4.897

Review 9.  Vaccine prevention of meningococcal disease in Africa: Major advances, remaining challenges.

Authors:  Mustapha M Mustapha; Lee H Harrison
Journal:  Hum Vaccin Immunother       Date:  2018-01-16       Impact factor: 3.452

10.  Seasonality of meningitis in Africa and climate forcing: aerosols stand out.

Authors:  L Agier; A Deroubaix; N Martiny; P Yaka; A Djibo; H Broutin
Journal:  J R Soc Interface       Date:  2012-12-05       Impact factor: 4.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.